Mutational burden of resectable pancreatic cancer by whole-transcriptome and whole-exome sequencing could predict a poor prognosis

Objectives Despite pancreatic cancer (PC) genomic characterization, true advances in the development of prognosis classification and new therapeutic strategies have yet to come. We aimed to better understand genomic alterations of invasive phenotype in order to improve patient selection for treatment options.

Source: Pancreatology - June 1, 2018 Category: Gastroenterology Authors: Elisa Grassi, Sandra Durante, Annalisa Astolfi, Giuseppe Tarantino, Valentina Indio, Eva Freier, Riccardo Casadei, Claudio Ricci, Francesca Comito, Daria Filippini, Francesca Formica, Carla Serra, Donatella Santini, Antonietta D'Errico, Francesco Minni, G Tags: 9. Experimental pancreatic cancer I Source Type: research